Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients (French, HTML)
Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients: French HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-12-02
Canada’s health care system is complex and involves the participation of multiple stakeholders, who all have distinct roles in the planning and delivery of healthcare services. Health Canada’s decision-making role in approving a drug for marketing is distinct from the roles of those who make decisions about price-setting and public drug plan reimbursements.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file